Summary
GLAXOSMITHKLINE'S potentially revolutionary inoculation against cervical cancer will take top billing as the drugs giant updates the market on its bulging pipeline of new vaccines later today.
The treatment, called Cervarix, is only one of a number of promising new pills and jabs under development.See the full content of this document
Extract
Blockbuster Hopes for Gsk
Jean Stephenne, head of GSK's biol...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
--Crisil Confirms Bb+/P4+ Ratings On Skb Builders India | thieves stabbed father for his iphone | take the reins at old coach house | Cahill On Call to Fire Aussies to Victory ; Blues Star's Tribute to Flood Victims | Edmunds.com Announces Wireless Availability to Automotive Information; Edmunds2Go, Mobile Access to Edmunds.com, Now Available to Consumers Via Palm VIIs, Web-enabled Cell ... | vistaprint.com moves its headquarters to massachusetts. | new operational and financial management team to run e4l's domestic direct response business. | announcing the healthgate quarterly financial conference call.
